Unlock instant, AI-driven research and patent intelligence for your innovation.
Traditional Chinese medicine composition and application thereof to preparation of drugs for treating pulmonary fibrosis diseases
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A composition and technology of traditional Chinese medicine, applied in the field of medicine, can solve the problem that it is difficult for medicine to achieve effective treatment
Active Publication Date: 2017-07-25
BINZHOU MEDICAL COLLEGE
View PDF2 Cites 7 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Image
Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
Click on the blue label to locate the original text in one second.
Reading with bidirectional positioning of images and text.
Smart Image
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0028] Embodiment 1. The preparation of Chinese medicine composition oral liquid
[0029] Take 300g of Astragalus, 200g of Codonopsis, 100g of Ophiopogon japonicus, 100g of Schisandra chinensis, 50g of Panax notoginseng, 100g of Zhebei, 100g of Anemarrhena, 50g of roasted licorice, the above eight flavors, add 20 liters of water, decoct twice, 2 hours each time, combine The decoction is concentrated to 10 liters, left to stand overnight, filtered, and the filtrate is added with 5% white granulated sugar and 0.01% potassium sorbate, filled and sterilized to obtain the product. Each bottle is equivalent to 10g of raw medicinal materials.
Embodiment 2
[0030] Embodiment 2. The preparation of Chinese medicine composition ointment
[0031] Take 300g Sun-roasted Astragalus, 180g Codonopsis, 120g Ophiopogon japonicus, 90g Southern Schisandra, 60g Panax notoginseng, 60g Zhebei, 60g Anemarrhena, 30g Zhigancao, the above eight flavors, add 20 liters of water, decoct twice, 2 hours each time, Combine the decoction liquid, concentrate to 10 liters, stand overnight, filter, and further concentrate the filtrate to a clear paste (density 1.1-1.5), add 5% white sugar and 0.01% potassium sorbate, fill and sterilize, to obtain . Each ml of extract is equivalent to 1g of the original medicinal material.
Embodiment 3
[0032] Embodiment 3. The preparation of Chinese medicine composition granule
[0033] Take 250g Astragalus, 200g Codonopsis, 150g Ophiopogon japonicus, 100g Southern Schisandra, 100g Panax notoginseng, 100g Chuanbei, 100g Anemarrhena, 50g roasted licorice, the above eight flavors, add 20 liters of water, decoct twice, 2 hours each time, combine After the decoction is concentrated to a clear paste, powdered sugar is added as an auxiliary material at a ratio of 1:1, mixed evenly, granulated, dried and packaged to obtain the product. Each bag is equivalent to 10g of raw medicinal materials.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
PUM
Login to View More
Abstract
The invention relates to a constitution and preparing method of a traditional Chinese medicine composition and application thereof to preparation of drugs for treating pulmonary fibrosis diseases. The composition is composed of radix astragali, radix codonopsis, radix ophiopogonis, fructus schizandrae, radix notoginseng, thunberg fritillary bulb, rhizoma anemarrhenae and licorice roots. The composition can regulate the expression of short-chain non-coding RNA (miRNAs) and long-chain non-coding RNA (incRNA), and can protect alveolar epithelial cells and interfere with the activity of myofibroblasts, so that the process of pulmonary fibrosis can be inhibited. Therefore, the composition is expected to be well applied to preparation of drugs for treating pulmonary fibrosis diseases.
Description
technical field [0001] The invention belongs to the technical field of medicine, and in particular relates to a traditional Chinese medicine composition and its application in preparing medicine for treating pulmonary fibrosis. Background technique [0002] Pulmonary fibrosis (PF) is a group of pulmonary interstitial diseases of unknown etiology, with progressively aggravated dyspnea as the most prominent clinical manifestation, and the main pathological features are alveolar epithelial cell damage, fibroblast activation, fibroblast Foci formation and excessive deposition of extracellular matrix eventually lead to abnormal remodeling of lungtissue architecture. The current treatment drugs are mainly corticosteroids, immunosuppressants, anti-inflammatory drugs, and cytotoxic drugs, but most patients are not sensitive to drugs, the disease progresses rapidly, and the mortality rate is high. Treatment is still an international problem. In the study of anti-pulmonary fibrosis ...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to View More 
Login to View More